KalVista Pharmaceuticals Inc (KALV)
12.13
-0.04
(-0.33%)
USD |
NASDAQ |
May 03, 16:00
12.14
+0.01
(+0.08%)
After-Hours: 20:00
KalVista Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| January 31, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.108 |
| December 31, 2015 | 0.0935 |
| September 30, 2015 | 0.0836 |
| June 30, 2015 | 0.0761 |
| March 31, 2015 | -0.2043 |
| December 31, 2014 | -0.1486 |
| September 30, 2014 | -0.1526 |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -0.0909 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2019
--
Maximum
Jul 2019
--
Average
--
Median
Jul 2019
Debt to Equity Ratio Benchmarks
| Haemonetics Corp | 0.9229 |
| Perspective Therapeutics Inc | 0.0229 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 113.97M |
| Total Liabilities (Quarterly) | 25.38M |
| Shareholders Equity (Quarterly) | 88.58M |